Back
BeOne Medicines Ltd. 10K Form
Sell
44
ONC
BeOne Medicines Ltd.
Last Price:
$331.69
Seasonality Move:
11.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ONC News And Ratings
See the #1 stock for the next 7 days that we like better than ONC
ONC Financial Statistics
Sales & Book Value
| Annual Sales: | $3.8B |
|---|---|
| Cash Flow: | $355.1M |
| Price / Cash Flow: | 71.43 |
| Annual Sales: | $37.33 |
| Price / Book: | 9.84 |
Profitability
| EPS (TTM): | 0.51970 |
|---|---|
| Net Income (TTM): | $69.6M |
| Gross Margin: | $3.1B |
| Return on Equity: | 1.92% |
| Return on Assets: | 1.1% |
BeOne Medicines Ltd. Earnings Forecast
Key BeOne Medicines Ltd. Financial Ratios
-
The Gross Profit Margin over the past 12 years for ONC is 81.15%.
-
The Selling, General & Administrative Expenses for ONC have been equal to 48.06% of Gross Profit Margin.
-
The Research & Development expenses have been 48.67% of Revenue.
-
The Net Earning history of ONC is -16.92% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 4 years.
BeOne Medicines Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ONC |
| Website: | beonemedicines.com |
Debt
| Debt-to-Equity Ratio: | 0.46 |
|---|---|
| Current Ratio: | 2.39 |
| Quick Ratio: | 2.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 52.47 |
ONC Technical Analysis vs Fundamental Analysis
Sell
44
BeOne Medicines Ltd. (ONC)
is a Sell
Is BeOne Medicines Ltd. a Buy or a Sell?
-
BeOne Medicines Ltd. stock is rated a SellThe current BeOne Medicines Ltd. [ONC] share price is $337.86. The Score for ONC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.